To read opinions and comments from users of dietary supplements, click here.

Malanoma

Melanoma is a very serious form of skin cancer. It begins in melanocytes— cells that make the skin pigment called melanin. Although melanoma accounts for only about 4% of all skin cancer cases, it causes most skin cancer-related deaths. The good news is that melanoma is often curable if it is detected and treated in its early stages.

In men, melanoma is found most often on the area between the shoulders and hips or on the head and neck. In women, melanoma often develops on the lower legs. It may also appear under the fingernails or toenails or on the palms or soles. The chance of developing melanoma increases with age, but it affects all age groups and is one of the most common cancers in young adults.

View Our Products

How Common Is Melanoma?
The number of new melanomas diagnosed in the United States is increasing. Since 1973, the rate of new melanomas diagnosed per year has more than doubled from 6 per 100,000 to 14 per 100,000.

The American Cancer Society estimates that about 51,400 new melanomas will be diagnosed in the United States during 2001. About 7,800 Cancer Statistics deaths will be attributed to malignant melanoma in 2001.¹

How Does Melanoma Develop?
When melanoma starts in the skin, it is called cutaneous melanoma. Melanoma may also occur in the eye (ocular melanoma or intraocular melanoma) and, rarely, in other areas where melanocytes are found, such as the digestive tract, meninges, or lymph nodes. When melanoma spreads (metastasizes), cancer cells are also found in the lymph nodes and possibly also other parts of the body, such as the liver, lungs, or brain. In these cases, the cancer cells are still melanoma cells, and the disease is called metastatic melanoma.

What Causes Melanoma?
The main cause of melanoma is thought to be related to spending too much time in the sun, which results in exposure to ultraviolet (UV) radiation. People with fair skin and who tend to sunburn easily — especially those with red or blond hair — may be at greatest risk because their skin cells have less melanin. Anyone who is exposed to large amounts of sunlight (such as a person who works outdoors, or who lives in areas where sunlight is very strong, like the American Southwest) is at a higher risk.

Here is an article on a link between bacterial infections and certain cancers. In these cases, we believe colloidal silver may very well be valuable as it is harmless and may kill these bacteria. Keep in mind, however, we are not doctors. This is just our opinion based on our experience with colloidal silver. 

View Our Products

Testimonial 1 
Is Bacterial Infection Carcinogenic?
by Kirstie Saltsman
Posted February 2, 2001 · Issue 95
from HMS BEAGLE

Abstract
Can bacteria cause cancer? The author discusses the discovery of a link between bacterial infection and cancer, the mechanisms by which bacteria cause cancer, and the potential for treatment.

Although his work was later called into question, Johannes Fibiger, the winner of the 1926 Nobel Prize in physiology, may not have been too far off the mark. He was awarded the prize for his discovery that a
parasitic worm, Spiroptera carcinoma, causes gastric tumors in rats.

While dissecting rats infected with the tuberculosis bacterium, he noticed that some had stomach growths, each of which contained a parasitic worm. The growths later proved to be unrelated to the
parasite, and doubt was even cast upon his assertion that the growths were malignant. Nevertheless, the idea that an infectious organism could cause cancer turned out to be accurate and groundbreaking.
Infectious organisms cause about 15% of cancers. By the early 1970s, nearly 30 mammalian oncoviruses had been discovered, and it is now estimated that over 15 percent of cancers worldwide are caused by infectious organisms. Although the idea that viruses can cause cancer has been accepted for decades, the idea that bacteria can cause cancer has begun to attract attention only recently. The most established instance of this is the link between Helicobacter pylori infection and gastric cancer, but bacterial infections have also been implicated in other types, such as colon and gall bladder cancers.
The mechanisms by which bacteria cause cancer appear to be quite different from those used by viruses. Viruses, by inserting their genomes into host cell chromosomes, can alter expression patterns of host cell genes and disrupt the intricately regulated process of growth control. Human papillomavirus (HPV), for example, which is associated with cervical cancer, induces cellular transformation by inhibiting the host cell tumor suppressors p53 and Rb. In addition, as in the case of human immunodeficiency virus (HIV), viral infection can cause depletion of the immune system, leaving the host less able to destroy cancerous or precancerous cells that arise by spontaneous mutation. Kaposi's sarcoma and non-Hodgkin's lymphoma are now considered AIDS-defining malignancies. 

Bacterial infections can cause tumors via inflammation. In contrast, bacteria are thought to cause cancer largely via an indirect mechanism. It seems that it is the host's response to infection - inflammation - which damages cells and predisposes them toward becoming cancerous. Phagocytes drawn to the site of infection release reactive oxygen and nitrogen species that can cause DNA mutations and damage cellular proteins and lipids. In addition, loss of cells at the site of infection stimulates cell proliferation in order to regenerate the tissue, a process that leaves the site vulnerable to tumor formation. Proliferating cells are one step closer to uncontrolled cell growth, and are also susceptible to acquiring mutations due to errors in DNA replication. Although inflammation and its molecular consequences are now known to be major risk factors in developing gastric adenocarcinoma
in those infected with H. pylori, it was not until fairly recently that a connection was made between the two. Although the association between H. pylori and gastric cancer is among the better known examples of a bacterial cause for cancer, Julie Parsonnet, associate professor of medicine at the Stanford University School of Medicine's proposed ERID (Emerging and Re-emerging Infectious Diseases) program, points out that it is not the first such association to be made. She says that "people have long recognized that chronic skin and bone infections with bacteria can lead to aggressive skin cancers."
Although it had been suspected for some time that a widespread environmental determinant was an etiologic factor in the development of gastric cancer, it was not until 1991 that H. pylori, a gram-negative, rod-shaped bacterium, was found to be involved. Over 50 percent of the world's population is infected with H. pylori; however, in most cases, infection has no serious clinical consequences. A complex interplay between host and bacterial factors seems to determine the outcome of infection. Among the bacterial factors is a group of genes - whose functions are largely unknown - localized in a cassette called the cag pathogenicity island. cag+ strains are more virulent than their cag-counterparts, and there is a strong correlation between infection with cag+ strains and the occurrence of both gastric cancer and duodenal ulcer disease. However, those with H. pylori-induced ulcers are less likely than the general population to contract gastric cancer, a finding that underscores the importance of host factors in disease outcome. Host genes influence susceptibility to bacterial tumorigenesis. Because host factors are thought to influence susceptibility to disease, a number of research teams are currently trying to pinpoint disease-predisposing genetic determinants within the host. Among those that are already known to influence the risk of gastric cancer is the gene for interleukin-1-beta (IL-1-beta). Elevated levels of this cytokine promote inflammation and suppress gastric acid secretion, which allows for more extensive bacterial colonization of the stomach. In an attempt to identify other host genes that influence the risk of gastric cancer, Karen Guillemin, a postdoctoral research fellow in Stanley Falkow's lab at Stanford University, has devised a strategy based  on the use of human DNA microarrays and a tissue culture model of infection. By comparing the host genes induced by the more virulent cagA+ strain with those induced by a cagA- strain, she has distinguished a subset that may be involved in disease. Some of these genes appear to be involved in cell signaling or in remodeling the cell ultrastructure, both of which may set a cell on a course toward malignancy. However, others are likely to promote cancer indirectly by promoting the growth of virulent strains. "Because infection with H. pylori is a long-term, often lifetime condition, and because H. pylori populations are known to undergo a lot of genetic changes and diversification, similar to viruses, a complexity that I think will emerge is that certain host genes will be found to promote particular gastric environmental conditions that select for more or less virulent bacteria," says Guillemin. Because only 1 percent of infected individuals have the misfortune of contracting the disease, genetic determinants within both host and bacteria are likely to affect the outcome of infection. Vaccination against H. pylori may fight cancer well. The finding that bacterial infections can cause cancer is exciting because unlike a genetic predisposition or an environmental factor, infections often can be treated or prevented. A recent study published in the Journal of the National Cancer Institute has shown regression of precancerous lesions upon treatment with antibiotics among a high-risk population in southwestern Columbia. Other studies are currently underway. However, the use of antibiotics is unlikely to take hold as a widespread preventive measure. The cost would preclude such a strategy, as would the risk of inducing the emergence of antibiotic-resistant strains. A more practical approach would be to induce protection by vaccination, and trials in mouse models of infection have already yielded promising results. Oral and intranasal vaccination has provided mucosal immunity, and systemic vaccination has also been shown to provide protection in the mouse model. It remains to be seen if these promising results will be reflected in  the human trials currently being undertaken. In 1966, Peyton Rous was awarded the Nobel Prize in medicine for his discovery that a virus (the Rous sarcoma virus) could cause cancer. Now, a mere 35 years later, a significant proportion of liver cancer is preventable thanks to a vaccine against hepatitis B. In addition, vaccines against human papillomavirus are now being tested in an effort to combat cervical cancer, and Epstein-Barr-virus-related tumors in HIV patients are becoming less common thanks to immunotherapy. Just as the discovery of the viral origin of certain cancers led to useful therapies, it is probably not overly optimistic to expect that the discovery of a link between bacterial infection and cancer will soon lead to effective treatments and eventually curtail the number of lives lost to this deadly disease. Kirstie Saltsman is a freelance biomedical writer based in Baltimore. She received her Ph.D. from Harvard in 1996 and did postdoctoral work at Stanford. 

Advanced Colloidal Silver and the other supplements we sell are not drugs and the information and opinions we offer are based upon use of these products as Dietary Supplements only. We have no doctors on staff and do not offer medical advice concerning colloidal silver, colloidal gold or any other dietary supplements. Although you may choose to supplement with colloidal silver, colloidal gold, and other mineral and vitamin supplements, we suggest that you consult a licensed physician if you believe you have a life threatening health issue. We also recommend that you do comprehensive research about colloidal silver, colloidal gold and all dietary supplements in general before accepting our opinions or the opinions of anyone else about how to care for your health.

The USFDA has not evaluated, nor rendered approval for any statements or research cited herein, nor have they approved any representations or opinions concerning colloidal silver, colloidal gold or any other dietary supplement products on this website. These products are dietary supplements and are not intended to diagnose, cure, prevent or treat any disease.

Utopia Silver Supplements does not assume the role of representative, fiduciary or surety on behalf of any person(s) or individual(s) unless expressly agreed in writing. Anyone purchasing our supplements are believed by us to be responsible adults who have exercised their right to do research and are making an informed decision. All rights are reserved, without prejudice.